Genetic Test
Xome
We genetically empower you, from helping you identify at-risk cohorts for a particular chronic disease to enabling data-driven management plans to help improve treatment outcomes.
Whole-Exome Sequencing (WES)
Our Xome product is based on Whole-exome sequencing (WES) technology, which efficiently captures the majority of genetic variations associated with diseases by focusing only on the protein-coding regions of the genome. Our WES product utilizes advanced target enrichment methods, reducing the cost and complexity of sequencing compared to whole genome sequencing.
Pharmacogenomics Analysis
With Xome, you can quickly and accurately identify genetic variants in protein-coding regions, including rare variants that can be missed with other sequencing methods. Xome also includes pharmacogenomics analysis to identify genetic variants that impact drug metabolism and response, enabling personalized medicine approaches and improving patient outcomes.
Quick and Highly Accurate
We understand that WES has its limitations, so we have designed our product with optimal sequencing depth to ensure high accuracy in variant calling. While non-coding regions are not sequenced with WES, Xome can be complemented with other targeted sequencing approaches or even whole genome sequencing to comprehensively identify genetic variants.
Ideal choice for Researchers and Clinicians
Our product is cost-effective and provides reliable results, allowing you to make informed decisions for your research or clinical practice. Xome is the ideal choice for researchers and clinicians who demand a reliable, cost-effective, and comprehensive solution for genetic analysis.
Order Your Xome Test with Wellytics
You can order Xome from Wellytics for an introductory price of,
₹16,000 /per test
The Comparison
Ultra
for prices
XomePlus
₹25,000
per test
Xome
₹16,000
per test
Sequencing Technology
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES) + Array
Whole Exome Sequencing (WES)
Coverage
Comprehensive, including non-coding regions (100% of genome)
Protein-coding regions only (1-2% of genome)
Protein-coding regions only (1-2% of genome)
Rare Variant Analysis
Customizable Panels
Polygenic Risk Score Analysis
-
Pharmacogenomics Analysis
Yes, including HLA and CNV analysis
-
Structural Variant Analysis
-
-
Ultra
for pricing
Whole Genome Sequencing (WGS)
Comprehensive, including non-coding regions (100% of genome)
Rare Variant Analysis
Structural Variant Analysis
Polygenic Risk Score Analysis
Pharmacogenomics Analysis(including HLA and CNV analysis)
Customizable Panels
XomePlus
₹25,000
per test
Whole Exome Sequencing (WES) + Array
Protein-coding regions only (1-2% of genome)
Rare Variant Analysis
Polygenic Risk Score Analysis
Pharmacogenomics Analysis(including HLA and CNV analysis)
Customizable Panels
Structural Variant Analysis
Xome
₹16,000
per test
Whole Exome Sequencing (WES)
Protein-coding regions only (1-2% of genome)
Rare Variant Analysis
Customizable Panels
Structural Variant Analysis
Polygenic Risk Score Analysis
Pharmacogenomics Analysis(including HLA and CNV analysis)